Dossier
Legislative
introduced
other
doctrine
resolution
introduced
proposed rule
passed chamber
executive action
final rule
enacted
district opinion
circuit opinion
opinion
Shandra Eisenga Human Cell and Tissue Product Safety Act
Key claim: The Shandra Eisenga Human Cell and Tissue Product Safety Act (S4885, 119th Congress) was introduced and referred to the Senate HELP Committee to address safety of human cell and tissue products.
Abstract
(S4885 · 119th Congress) Latest action (2026-06-24): Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Why this matters
Human cell and tissue products (HCT/Ps) are regulated by FDA under a distinct framework from drugs and devices, and safety gaps have periodically surfaced in areas like tissue banking and regenerative medicine. A named safety bill signals congressional interest in tightening oversight, though at referral stage the practical implications for providers, tissue processors, and patients are not yet defined.